Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Our current price ...

Mar 13, 2007 06:04AM

Mar 13, 2007 06:05AM

Mar 13, 2007 06:12AM
ARTICLE 8 DISSOLUTION AND WINDING UP 8.1 Dissolution. The Company shall be dissolved, its assets shall be disposed of, and its affairs wound up on the first to occur of the following: (a) The written agreement of Members holding at least 75% of the Percentage Interests to dissolve the Company; or (b) The entry of a decree of judicial dissolution under Section 18-802 of the Act. Except for the foregoing, the Company shall not dissolve on the occurrence of any other event. 8.2 Winding Up. Upon the occurrence of any event specified in Section 8.1, the Management Committee promptly shall notify each of the Members, and the Company shall continue solely for the purpose of, and immediately begin the process of, winding up its affairs in an orderly manner, liquidating its assets, and satisfying the claims of its creditors. The Management Committee shall promptly appoint a Person to act as the liquidator of the Company (the "Liquidator") who shall be responsible for overseeing the winding up and liquidation of the Company pursuant to the terms of this Operating Agreement. The Liquidator shall give written notice of the commencement of winding up by mail to all known creditors and claimants whose addresses appear on the records of the Company. 22 8.3 Reversion of Rights. Upon the occurrence of any event specified in Section 8.1, or upon the valid termination of the Commercialization Agreement by the Company, all of the rights granted by each of Patriot and TPL to the Company pursuant to the P-Newco License and T-Newco License, respectively, shall immediately and without further action by any of the parties thereto revert in their entirety to each of Patriot and TPL, respectively.

Mar 13, 2007 07:20AM
Share
New Message
Please login to post a reply